UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials

Breast cancer research and treatment, 2018-11, Vol.172 (1), p.9-21

2018

Volltextzugriff (PDF)

New emerging targets in cancer immunotherapy: the role of GITR

ESMO open, 2020-08, Vol.4 (Suppl 3), p.e000738-e000738, Article e000738

2020

Volltextzugriff (PDF)

Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study

British journal of cancer, 2020-05, Vol.122 (11), p.1611-1617

2020

Volltextzugriff (PDF)

Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer

International journal of molecular sciences, 2022-06, Vol.23 (11), p.6320

2022

Volltextzugriff (PDF)

The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer Diagnosis

Journal of clinical medicine, 2023-11, Vol.12 (23), p.7236

2023

Volltextzugriff (PDF)

Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer

BMC palliative care, 2024-05, Vol.23 (1), p.129-9, Article 129

2024

Volltextzugriff (PDF)

Periostin: A Novel Prognostic and Therapeutic Target For Genitourinary Cancer?

Clinical genitourinary cancer, 2014-10, Vol.12 (5), p.301-311

2014

Volltextzugriff (PDF)

Diversity of Cardiologic Issues in a Contemporary Cohort of Women With Breast Cancer

Frontiers in cardiovascular medicine, 2021-10, Vol.8, p.654728

2021

Volltextzugriff (PDF)

Cascade testing in Italian Hereditary Breast Ovarian Cancer families: a missed opportunity for cancer prevention?

Familial cancer, 2024-06, Vol.23 (2), p.197-207

2024

Volltextzugriff (PDF)

Germline TP53 pathogenic variants and breast cancer: A narrative review

Cancer treatment reviews, 2023-03, Vol.114, p.102522-102522, Article 102522

2023

Volltextzugriff (PDF)

Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways

Critical reviews in oncology/hematology, 2024-07, Vol.199, p.104379, Article 104379

2024

Volltextzugriff (PDF)

Safety of antiandrogen therapy for treating prostate cancer

Expert opinion on drug safety, 2014-11, Vol.13 (11), p.1483-1499

2014

Volltextzugriff (PDF)

Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial

Tumori, 2023-02, Vol.109 (1), p.71-78

2023

Volltextzugriff (PDF)

Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review

Clinical Medicine Insights: Reproductive Health, 2019, Vol.13, p.1179558119864584-1179558119864584

2019

Volltextzugriff (PDF)

Experience with a nurse‐driven genetic counseling pathway of Italian women with uninformative BRCA test result

Journal of genetic counseling, 2023-02, Vol.32 (1), p.140-152

2023

Volltextzugriff (PDF)

CDK inhibitors in advanced HR+ Her 2- breast cancer: A systematic review and meta-analysis of randomized trials

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e13047-e13047

2018

Volltextzugriff (PDF)

Abstract P3-09-03: Single nucletotide polymorphisms of aromatase gene ( CYP19A1 ) and toxicity of adjuvant aromatase inhibitors: A translational, prospective study

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P3-P3-09-03

2022

Volltextzugriff (PDF)

Fertility and Pregnancy-Related Issues in Young BRCA Carriers With Breast Cancer

Breast cancer : basic and clinical research, 2024-01, Vol.18, p.11782234241261429-11782234241261429

2024

Volltextzugriff (PDF)

Genitourinary tumours in the targeted therapies era: new advances in clinical practice and future perspectives

Anti-cancer drugs, 2016-11, Vol.27 (10), p.917-943

2016

Volltextzugriff (PDF)

Fertility and Pregnancy-Related Issues in Young Carriers With Breast Cancer

Breast cancer : basic and clinical research, 2024-06, Vol.18

2024

Volltextzugriff (PDF)

Immunotherapy for genitourinary cancer: state of the art and new perspectives

Anti-cancer drugs, 2016-08, Vol.27 (7), p.585-599

2016

Volltextzugriff (PDF)

Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e16506-e16506

2018

Volltextzugriff (PDF)

Cisplatin (C)-paclitaxel (P) chemotherapy (CT) regimen with concurrent radiotherapy (RT) in local advanced (LACC) or recurrent (LRCC) cervical cancer: 14 year-results of a phase II study

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.5529-5529

2016

Volltextzugriff (PDF)

Abstract 1011: RNAseq analysis obtained from on-purpose tumor biopsies of patients in the MATCH-R trial allows the identification of potential mechanisms of acquired resistance to PD(L)1 therapies

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1011-1011

2017

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Oncology
(12)
Breast Cancer
(11)
Humans
(11)
Chemotherapy
(6)
Female
(6)
Cancer Therapies
(5)
Review
(5)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(3)
Breast Neoplasms - Pathology
(3)
Cancer
(3)
Cardiac & Cardiovascular Systems
(3)
Cardiovascular System & Cardiology
(3)
Endocrine Therapy
(3)
Erbb-2 Protein
(3)
Medical Prognosis
(3)
Metastasis
(3)
Mutation
(3)
Pharmacology & Pharmacy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials

New emerging targets in cancer immunotherapy: the role of GITR

Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study

Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer

Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus Review

The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer Diagnosis

Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer

Periostin: A Novel Prognostic and Therapeutic Target For Genitourinary Cancer?

Diversity of Cardiologic Issues in a Contemporary Cohort of Women With Breast Cancer

Cascade testing in Italian Hereditary Breast Ovarian Cancer families: a missed opportunity for cancer prevention?

Germline TP53 pathogenic variants and breast cancer: A narrative review

Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways

Safety of antiandrogen therapy for treating prostate cancer

Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial

Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review

Experience with a nurse‐driven genetic counseling pathway of Italian women with uninformative BRCA test result

CDK inhibitors in advanced HR+ Her 2- breast cancer: A systematic review and meta-analysis of randomized trials

Abstract P3-09-03: Single nucletotide polymorphisms of aromatase gene ( CYP19A1 ) and toxicity of adjuvant aromatase inhibitors: A translational, prospective study

Fertility and Pregnancy-Related Issues in Young BRCA Carriers With Breast Cancer

Genitourinary tumours in the targeted therapies era: new advances in clinical practice and future perspectives

Fertility and Pregnancy-Related Issues in Young Carriers With Breast Cancer

Immunotherapy for genitourinary cancer: state of the art and new perspectives

Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study

Cisplatin (C)-paclitaxel (P) chemotherapy (CT) regimen with concurrent radiotherapy (RT) in local advanced (LACC) or recurrent (LRCC) cervical cancer: 14 year-results of a phase II study

Abstract 1011: RNAseq analysis obtained from on-purpose tumor biopsies of patients in the MATCH-R trial allows the identification of potential mechanisms of acquired resistance to PD(L)1 therapies

Suchergebnisse filtern